Please assess the completion status of the following clinical trial:

Trial Title: Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* more or equal than 18 years old,~* patient with triple antihypertensive therapy (maximum tolerated dose) with a diuretic, except for anuric patients, and without modification treatment:~* in the last two months,~* expected in the next three months,~* renal transplanted patients with native kidneys followed for hypertension before transplant, and having a arterial systolic pressure ≥ 160 mmHg on the average of 3 measurements taken during the screening consultation and during at least one previous consultation OR~* chronic renal failure patient with dialysis and having a arterial systolic pressure ≥ 160 mmHg on the average of 3 measurements taken during the screening consultation and during at least one previous consultation~* patient affiliated to social security or similarly regime~* patient who signed the consent to participate in the study~No Inclusion Criteria:~* renal artery anatomy against-indicating the procedure including:~* 3 homolateral renal arteries~* kidney surgery including bypass surgery or renal artery reimplantation~* volume-dependent type of hypertension~* secondary hypertension (not included nephropathy)~* orthostatic hypotension associated with symptoms during the previous year~* medical history including:~  * acute coronary syndrome, unstable angina, stroke within 6 months preceding the period of inclusion,~ * surgery scheduled on the kidney, the renal arteries or the retroperitoneum during patient participation in the study period~ * chronic alcoholism~* anticoagulants or antiplatelet agents for which a therapeutic window can not be considered (except aspirin dose less than or equal to 160mg / day)~* contraindication to the realization of an MRI~* included in another trial assessing a medicament or a medical device or a surgical procedure~* protected person referred to in Articles L1121-5 to L1121-8 of the Code of Public Health

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Renal sympathicolysis (Type: EXPERIMENTAL): The patient will have:~1. Ambulatory Blood Pressure Monitoring~2. Magnetic Resonance Angiography~3. Blood test~4. Renal sympathicolysis~5. Ambulatory Blood Pressure Monitoring~6. Magnetic Resonance Angiography

Based on this trial design, predict the completion outcome and termination type (if applicable).